Vaccines
21 June 2017
NanoBio And Porton Biopharma Receive Approval To Advance Next Generation Anthrax Vaccine21 June 2017
Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine13 June 2017
Aimmune Therapeutics Reports on Up-Dosing in Its Ongoing Phase 3 PALISADE Trial of AR101 for Peanut Allergy13 June 2017
Autoantigen GAD-Vaccine is Safe for Children at High Risk for Developing Type 1 Diabetes11 June 2017
Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer6 June 2017
NIH and Themis Bioscience announce the initiation of a clinical trial of a Chikungunya vaccine5 June 2017
Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual MeetingNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports